Edward B Garon Selected Research

Edward B Garon Research Topics

Disease

81	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 07/2010
53	Neoplasms (Cancer) 01/2022 - 08/2007
19	Disease Progression 04/2022 - 02/2012
17	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2011
7	Fatigue 01/2021 - 12/2013
5	Neoplasm Metastasis (Metastasis) 10/2021 - 12/2012
4	Melanoma (Melanoma, Malignant) 12/2020 - 01/2017
4	Febrile Neutropenia 01/2020 - 12/2013
4	Hypertension (High Blood Pressure) 01/2020 - 08/2014
4	Circulating Neoplastic Cells 01/2020 - 06/2012
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 06/2012
3	Neutropenia 01/2020 - 12/2013
3	Pneumonia (Pneumonitis) 12/2019 - 01/2018
3	Thrombocytopenia (Thrombopenia) 11/2019 - 06/2012
3	Adenocarcinoma 01/2018 - 10/2012
2	Pneumothorax 11/2021 - 12/2019
2	Brain Neoplasms (Brain Tumor) 08/2021 - 10/2020
2	Carcinogenesis 04/2021 - 01/2021
2	Dyspnea (Shortness of Breath) 01/2021 - 10/2020
2	Cough 10/2020 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2015 - 07/2010
1	Second Primary Neoplasms (Neoplasms, Second) 01/2022
1	Mesothelioma 01/2022
1	Residual Neoplasm 01/2022
1	Hypoxia (Hypoxemia) 01/2021
1	Pain (Aches) 10/2020
1	Inflammation (Inflammations) 03/2020
1	Myocardial Infarction 03/2020
1	Chest Pain (Chest Pains) 01/2020
1	Cellulitis 12/2019
1	Pleural Empyema (Pyothorax) 12/2019
1	Dermatitis 12/2019
1	Fever (Fevers) 12/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2019
1	Small Cell Carcinoma 11/2019

Drug/Important Bio-Agent (IBA)

24	pembrolizumabIBA 10/2021 - 04/2015
18	Biomarkers (Surrogate Marker)IBA 04/2022 - 02/2012
18	RamucirumabIBA 01/2022 - 11/2012
15	Docetaxel (Taxotere)FDA Link 10/2021 - 11/2012
14	PlatinumIBA 01/2022 - 11/2012
12	ErbB Receptors (EGF Receptor)IBA 01/2022 - 11/2011
12	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 11/2011
10	Pemetrexed (MTA)FDA Link 01/2022 - 10/2013
10	Immune Checkpoint InhibitorsIBA 01/2022 - 04/2015
9	B7-H1 AntigenIBA 10/2021 - 05/2018
8	Tyrosine Kinase InhibitorsIBA 10/2021 - 01/2013
8	LigandsIBA 08/2021 - 01/2018
6	NivolumabIBA 01/2021 - 10/2015
6	Bevacizumab (Avastin)FDA Link 10/2017 - 11/2012
5	Monoclonal AntibodiesIBA 03/2020 - 01/2017
5	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 10/2013
4	Proteins (Proteins, Gene)FDA Link 04/2021 - 02/2012
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 12/2013
3	Cell-Free Nucleic AcidsIBA 01/2022 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 12/2019
3	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 10/2017
3	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 01/2019 - 06/2013
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 05/2013 - 07/2010
2	osimertinibIBA 04/2022 - 01/2021
2	Aromatase (CYP19)IBA 04/2021 - 12/2012
2	tremelimumabIBA 01/2021 - 01/2020
2	durvalumabIBA 01/2021 - 01/2020
2	Peptides (Polypeptides)IBA 12/2020 - 06/2012
2	dacomitinibIBA 05/2019 - 01/2017
2	Biological ProductsIBA 01/2019 - 06/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2019 - 06/2013
2	Estrogen Receptor Modulators (Antiestrogen)IBA 01/2018 - 03/2013
2	Anaplastic Lymphoma KinaseIBA 01/2018 - 03/2016
2	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2018 - 10/2017
2	CrizotinibIBA 01/2018 - 02/2015
2	Fulvestrant (Faslodex)FDA Link 01/2018 - 03/2013
2	Epidermal Growth Factor (EGF)IBA 12/2017 - 01/2015
2	Pharmaceutical PreparationsIBA 02/2015 - 12/2013
2	Estrogen ReceptorsIBA 01/2015 - 03/2013
1	DV281IBA 01/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020
1	Glutamic Acid (Glutamate)FDA Link 12/2020
1	Amino Acids FDA Link 12/2020
1	VaccinesIBA 11/2020
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2020
1	canakinumab FDA Link 03/2020
1	InflammasomesIBA 03/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2020
1	C-Reactive ProteinIBA 03/2020
1	InterleukinsIBA 03/2020
1	NucleotidesIBA 03/2020
1	CytokinesIBA 03/2020
1	Circulating Tumor DNAIBA 01/2020
1	capmatinibIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	CTLA-4 AntigenIBA 01/2020
1	Alanine Transaminase (SGPT)IBA 12/2019

Therapy/Procedure

34	Therapeutics 01/2022 - 08/2007
21	Drug Therapy (Chemotherapy) 01/2022 - 09/2012
14	Immunotherapy 01/2022 - 10/2015
3	Radiotherapy 01/2018 - 10/2013
2	Retreatment 11/2020 - 10/2020
1	Chest Tubes (Chest Tube) 11/2021
1	Injections 11/2021
1	Duration of Therapy 01/2020